Angioedema Biomarker Research Study
Part of paid clinical trials in Wheaton, Maryland.
- Sponsor
- Foundation For Rare Disease Research
- Study ID
- NCT06210698
- Status
- Recruiting
Conditions
- ACE Inhibitor-Induced Angioedema
- Angioedema
- Angioedemas, Hereditary
- C1 Inhibitor Deficiency
- Indolent Systemic Mastocytosis
- Mastocytosis
- Systemic Mastocytoses
- Urticaria
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Venipuncture — DIAGNOSTIC_TESTvenipuncture
Study Details
This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combination, in comparison to currently available commercial tests. The ultimate goal is to establish the feasibility of developing an affordable and accurate laboratory test capable of diagnosing the diverse etiological manifestations of angioedema.
Key Dates
- First listed
- Jan 18, 2024
- Start date
- Jan 15, 2024
- Status verified
- Aug 2026
- Primary completion
- Jul 31, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: Recurrent AngioedemaBroad definition: Angioedema due to urticaria (histaminergic/mast-cell) or non-urticarial (non-histaminergic) etiology Narrow definition: non-urticarial angioedema - distinguishing between C1-Inhibitor deficiency/dysfunction, and Angioedema with normal levels of C1-Inhibitor.
- Arm: Healthy SubjectsBroad definition: No medical history of angioedema of any kind, including urticaria (histaminergic) or drug-induced angioedema (e.g. ACE-Inhibitor angioedema)
Primary Outcome Measure
Novel versus traditional diagnostic blood test for angioedema [ Time Frame: 2 years ]
Central Contacts
- Henry Li, MD, PhD877-888-2973
- Joseph Chiao, MD8778882973
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Institute for Asthma and Allergy Clinical Research | Wheaton | Maryland | 20902 | Lili Wan, PhD Henry LI, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Wheaton, MD
Related Studies
- Study of Factors Regulating Mast Cell ProliferationRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary AngioedemaPHASE2/PHASE3 · Enrolling By Invitation · Pharvaris Netherlands B.V. · Birmingham, Alabama
- Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema PatientsPHASE1/PHASE2 · Recruiting · Institute for Asthma and Allergy · Wheaton, Maryland
- An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)Recruiting · Blueprint Medicines Corporation · Wheaton, Maryland